We are live on ! Find out more
AVNR

AVANIR PHARMACEUTICALS, INC CL A
AVNR

Delisted

AVNR was delisted on the 12th of January, 2015.

Back to rankings

Fund managers haven’t disclosed any holdings of AVNR yet.

AVNR Hedge Fund Activity: Q1 2016 in Review

0 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) for Q1 2016, worth a combined $0 — down 100% from $12K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of AVNR and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Crosspoint Capital Strategies, exiting entirely with an estimated $12K sold.

  • 0 institutional investors held AVANIR PHARMACEUTICALS, INC CL A (AVNR) as of Q1 2016, down from 1 in Q4 2015.
  • Funds reported $0 of AVANIR PHARMACEUTICALS, INC CL A stock for Q1 2016, down 100% quarter-over-quarter.
  • 0 funds opened new AVANIR PHARMACEUTICALS, INC CL A positions in Q1 2016 and 1 closed out, a net change of -1 holder.
  • The largest AVANIR PHARMACEUTICALS, INC CL A seller in Q1 2016 was Crosspoint Capital Strategies, an estimated $12K sold.

Based on aggregated 13F filings for Q1 2016.